SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report: April 5, 1999
WASATCH PHARMACEUTICAL, INC.
----------------------------------------------------
(Exact name of registrant as specified in its charter)
UTAH 000-22899 84-0854009
- ---------------------------- ------------------------ ---------------------
(State or other jurisdiction (Commission File Number) (IRS Employer ID No.)
of incorporation)
714 East 7200 South, Midvale, Utah 84047
---------------------------------------------------
(Address of principal executive office)
Registrant's telephone number, including area code: (801) 566-9688
----------------
N/A
------------------------------------------------------------------------
(Former name or former address, if changed since last report)
ITEM 5. OTHER EVENTS
Summary
On March 3, 1999, Wasatch Pharmaceutical, Inc., a Utah corporation (the
"Company") entered into a Financial Consulting Agreement with The Vector Group,
LLC, a California Limited Liability Company, ( "Vector"), wherein Vector has
agreed to perform investment banking services including:
Creating and executing plans for the financing of the expansion and
growth of the operations of the Company, including public or private offerings
of the Company's securities.
The Vector Group will receive 1,500,000 shares of common stock as
compensation.
(c) (1) Exhibits. The following exhibits are included as part of this report:
SEC
Exhibit Reference
Number Number Title of Document Location
- ------- ------ -------------------------------------------- --------
10.01 10 Agreement between The Vector Group This filing
and Wasatch Pharmaceutical, Inc. dated
March 3, 1999.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunder duly authorized.
WASATCH PHARMACEUTICAL, INC.
Date: April 5, 1999 /s/ David K. Giles
-----------------------
David K. Giles, Secretary